Evaluation of a sensor algorithm for motor state rating in Parkinson's disease

Parkinsonism Relat Disord. 2019 Jul:64:112-117. doi: 10.1016/j.parkreldis.2019.03.022. Epub 2019 Mar 26.

Abstract

Introduction: A treatment response objective index (TRIS) was previously developed based on sensor data from pronation-supination tests. This study aimed to examine the performance of TRIS for medication effects in a new population sample with Parkinson's disease (PD) and its usefulness for constructing individual dose-response models.

Methods: Twenty-five patients with PD performed a series of tasks throughout a levodopa challenge while wearing sensors. TRIS was used to determine motor changes in pronation-supination tests following a single levodopa dose, and was compared to clinical ratings including the Treatment Response Scale (TRS) and six sub-items of the UPDRS part III.

Results: As expected, correlations between TRIS and clinical ratings were lower in the new population than in the initial study. TRIS was still significantly correlated to TRS (rs = 0.23, P < 0.001) with a root mean square error (RMSE) of 1.33. For the patients (n = 17) with a good levodopa response and clear motor fluctuations, a stronger correlation was found (rs = 0.38, RMSE = 1.29, P < 0.001). The mean TRIS increased significantly when patients went from the practically defined off to their best on state (P = 0.024). Individual dose-response models could be fitted for more participants when TRIS was used for modelling than when TRS ratings were used.

Conclusion: The objective sensor index shows promise for constructing individual dose-response models, but further evaluations and retraining of the TRIS algorithm are desirable to improve its performance and to ensure its clinical effectiveness.

Keywords: Independent evaluation; Levodopa challenge test; Machine learning algorithms; Parkinson's disease; Wearable sensors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Accelerometry
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / administration & dosage*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Levodopa / administration & dosage*
  • Male
  • Middle Aged
  • Motor Activity / drug effects*
  • Parkinson Disease / drug therapy*
  • Support Vector Machine*
  • Wearable Electronic Devices*

Substances

  • Antiparkinson Agents
  • Levodopa